Rupert Vessey, Bristol Myers Squibb's President of Research and Early Development
Protein degradation field turns red hot as Bristol Myers signs up for another multibillion-dollar pact
A new season of protein degradation deals is upon us.
Just days after Rupert Vessey anted up on a $1.55 billion deal to advance new …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
